Fortress Biotech Q2 EPS $(0.07) Up From $(0.10) YoY, Sales $17.39M Down From $18.89M YoY
Portfolio Pulse from Benzinga Newsdesk
Fortress Biotech (NASDAQ:FBIO) reported Q2 losses of $(0.07) per share, a 30% improvement from $(0.10) per share YoY. However, sales decreased by 7.94% to $17.39 million from $18.89 million YoY.
August 14, 2023 | 8:48 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Fortress Biotech reported improved Q2 losses but a decrease in sales YoY.
While Fortress Biotech has managed to reduce its losses compared to the same period last year, the decrease in sales could be a concern for investors. This mixed result may lead to neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100